Boston Scientific Corp (BSX)vsInteger Holdings Corp (ITGR)
BSX
Boston Scientific Corp
$51.42
+0.45%
HEALTHCARE · Cap: $71.14B
ITGR
Integer Holdings Corp
$125.08
+0.03%
HEALTHCARE · Cap: $4.12B
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 1031% more annual revenue ($21.00B vs $1.86B). BSX leads profitability with a 17.5% profit margin vs 7.6%. BSX appears more attractively valued with a PEG of 0.67. BSX earns a higher WallStSmart Score of 72/100 (B).
BSX
Strong Buy72
out of 100
Grade: B
ITGR
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-31.7%
Fair Value
$39.04
Current Price
$51.41
$12.38 premium
Margin of Safety
+7.8%
Fair Value
$94.60
Current Price
$125.08
$30.48 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Strong operational efficiency at 22.9%
Generating 1.3B in free cash flow
Earnings expanding 52.9% YoY
Reasonable price relative to book value
Areas to Watch
Distress zone — elevated risk
Premium valuation, high expectations priced in
0.5% revenue growth
Grey zone — moderate risk
7.6% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Price/Book. Profitability is solid with margins at 17.5% and operating margin at 22.9%. PEG of 0.67 suggests the stock is reasonably priced for its growth.
Bull Case : ITGR
The strongest argument for ITGR centers on EPS Growth, Price/Book.
Bear Case : BSX
The primary concerns for BSX are Altman Z-Score.
Bear Case : ITGR
The primary concerns for ITGR are P/E Ratio, Revenue Growth, Altman Z-Score.
Key Dynamics to Monitor
BSX profiles as a mature stock while ITGR is a value play — different risk/reward profiles.
ITGR carries more volatility with a beta of 0.64 — expect wider price swings.
BSX is growing revenue faster at 7.5% — sustainability is the question.
BSX generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (72/100 vs 51/100), backed by strong 17.5% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Integer Holdings Corp
HEALTHCARE · MEDICAL DEVICES · USA
Integer Holdings Corporation is an outsourced manufacturer of medical devices in the United States, Puerto Rico, Costa Rica, and internationally. The company is headquartered in Plano, Texas.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?